Pentazocine

This classification denotes an opioid receptor agonist and opioid with the molecular formula C19H27NO, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier RP4A60D26L, chemically known as 1,2,3,4,5,6-hexahydro-6,11-dimethyl-3-(3-methylbut-2-enyl)-2,6-methano-3-benzazocin-8-ol but generally known as pentazocine, which bears US NIH Compound Identifier 4736. European Medicines Agency schedules Pentazocine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09688MIG. The term PENTAZOCINE is an International Non-Proprietary Name. World Health Organization schedules pentazocine in its Anatomical Therapeutic Chemical (ATC) Classification. PENTAZOCINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule pentazocine under HS 29333300 and SITC 51574. As of Q4 2014, PENTAZOCINE remains the US FDA Preferred Term for this commodity. Pentazocine bears US NLM identifiers UMLS ID C0030873 and NCI Concept Code C61884. SMILES: OC1CC2C3(C(C(N(CC3)C/C=C(/C)C)CC2CC1)C)C.